财中社1月9日电药师帮(09885)发布公告,董事会宣布根据2023年股份激励计划,于2025年1月9日通过信托安排,受托人在市场上回购本公司12万股股份,总代价为69万港元,平均价格为每股5.77港元。此次回购的目的是为了满足根据股份激励计划授出的奖励,并补充信托基金。
董事会指出,目前公司股价低于其内在价值,未能充分反映公司的业务前景,认为此次回购为提升公司股东价值提供了良好机会。同时,此举也展示了公司对未来发展的信心,有助于吸引和留住人才,以推动关键员工的利益与公司利益一致,促进集团的可持续发展。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.